Cardiol Therapeutics Inc. Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss
Cardiol Therapeutics Inc. (CRDL) reported Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss of -CAD 1.18 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Operating Expenses
ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss · last filed 2026-03-31
| Period end | Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss 12 month |
|---|---|
| 2025-12-31 | -1.18M CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 2.14M CAD 40-F · filed 2026-03-31 |
| 2023-12-31 | -712.72K CAD 40-F · filed 2025-03-31 |
| 2022-12-31 | 2.76M CAD 20-F · filed 2024-04-01 |
| 2021-12-31 | 1.89M CAD 20-F · filed 2024-04-01 |
| 2020-12-31 | -34.45K CAD 20-F · filed 2023-03-29 |